OA management guidelines forgo treatment hierarchy or order but emphasize severity, patient risk factors

By Jeff Craven

 

The guidelines lay out a wide range of treatment options without an algorithm.

***

 

You can take the MDedge Podcasts survey by clicking here.

 

***

 

Other news:

Colchicine cut post-MI CVD events

Colchicine fulfilled the promise first seen in CANTOS that anti-inflammatory treatment can reduce cardiovascular disease events.

 

Large population-based study underscores link between gout, CVD event risk

The relationships between gout and fatal and nonfatal CVD events weren’t weakened by allopurinol use or serum urate lowering to treatment target.

 

Baseline subtypes predict dementia and death in patients with Parkinson’s disease

Clinicians should assess cognitive and psychiatric symptoms at baseline.

 

Metformin after gestational diabetes: Lessons from landmark diabetes prevention trial

The drug should be front and center for clinicians who hope to stave off the “remarkable” incidence of type 2 diabetes after GDM.

 

You can contact the MDedge Daily Medical News by emailing us at [email protected] or following us on Twitter at @MDedgeTweets.